Oncolytics Biotech Inc T.ONC

Todays news another win for Roche colaboration

[canadafan]

Todsys news , another advancement alongside the Roche Gobblet cotherapy.
amazing volume over 11millionnshares premarket.
was up over 35% at one  time.
premarket can be strange. Regardless of price.
this additional data & yet another registration opportunity, gives great negotiations with Roche.

[spesestsemper]

very interesting pre market . 25 million shares and the price has barely budged . I'm assumng the shorts are covering . Any traders out there with some insight ?

[canadafan]

The price did spike to over $1.17 on the nas premarket. Lots of very small trades, , yet the largest I saw was 6000 sahres. Can be views on nasdaq site. They have historicall trades, listed by hour. My guess lots of automated trades. There were many less than 200 shares. Im not into trading , but do watch way too close. Todays news was great. Most likely as you say a lot of short covering, which

[spesestsemper]

actually went to $1.24 early but now it is .77 on over 26 million . Has to be more than short covering .

[spesestsemper]

almost 27 million premarket now , about .80 . Don't know if this is a good or bad sign . Like the crazy volume but don't like the price . News release was ok but I don't think it justified the volume . Has to be something else lurking out there . Or it could be just the market makers playing around . I hate the manipulation 

[jh1970]

Next logical news should be partnership , maybe they know what we do not.

[jh1970]

Wow, big red opening. Why ?

[jh1970]

I smell next financing with shorts.

[canadafan]

There was a record number of shares traded, premarket @ 24+ million shares, on the Nas. The price was all over the place. Again, many small trades. Indicating in- place orders. computer trading, if Onc  ATM , I could not see the larger trades. historically they do that in 10k blocks. now that market is open, a lot if dust has to settle. Todsys news is very good.  Still need time

[Quentin30]

This is just more nothing burger news, that's why. We're still in Phase I trials... ONCY has been in Phase I trials for 25 years, with the same drug. Financial markets don't care... they want to know how ONCY is going to pay for Phase III... and this management team has 2 quarters to achieve this... or the money runs out... question is, are we now seeing lower lows, and lower highs

[venture009]

Interesting action with over 27 million traded. Although the news is positive we are talking a safety analysis.  After 25 years one would hope we would have progressed much farther along than safety. We never seem to do much after safety.